[go: up one dir, main page]

NO20012541L - Use of phosphonomauric acid derivatives for the treatment of infections - Google Patents

Use of phosphonomauric acid derivatives for the treatment of infections

Info

Publication number
NO20012541L
NO20012541L NO20012541A NO20012541A NO20012541L NO 20012541 L NO20012541 L NO 20012541L NO 20012541 A NO20012541 A NO 20012541A NO 20012541 A NO20012541 A NO 20012541A NO 20012541 L NO20012541 L NO 20012541L
Authority
NO
Norway
Prior art keywords
phosphonomauric
infections
treatment
acid derivatives
compound
Prior art date
Application number
NO20012541A
Other languages
Norwegian (no)
Other versions
NO20012541D0 (en
Inventor
Hassan Jomaa
Original Assignee
Jomaa Pharmaka Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jomaa Pharmaka Gmbh filed Critical Jomaa Pharmaka Gmbh
Publication of NO20012541D0 publication Critical patent/NO20012541D0/en
Publication of NO20012541L publication Critical patent/NO20012541L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)

Abstract

Oppfinnelsen angår anvendelse av en forbindelse av formel (I). for profylakse og terapi av infeksiøse prosesser i mennesker og dyr, hvilke prosesser fremkalles av bakterier, fungi eller parasitter. Forbindelsen ifølge oppfinnelsen anvendes også som fungicid, baktericid eller herbicid middel i planter.The invention relates to the use of a compound of formula (I). for prophylaxis and therapy of infectious processes in humans and animals, which processes are caused by bacteria, fungi or parasites. The compound of the invention is also used as a fungicide, bactericide or herbicide in plants.

NO20012541A 1998-11-25 2001-05-23 Use of phosphonomauric acid derivatives for the treatment of infections NO20012541L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854402A DE19854402A1 (en) 1998-11-25 1998-11-25 Use of phosphonoformic acid derivatives for the therapeutic and prophylactic treatment of infections
PCT/EP1999/008965 WO2000030625A2 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections

Publications (2)

Publication Number Publication Date
NO20012541D0 NO20012541D0 (en) 2001-05-23
NO20012541L true NO20012541L (en) 2001-07-24

Family

ID=7888997

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012541A NO20012541L (en) 1998-11-25 2001-05-23 Use of phosphonomauric acid derivatives for the treatment of infections

Country Status (16)

Country Link
EP (1) EP1131075A2 (en)
JP (1) JP2002530326A (en)
CN (1) CN1328465A (en)
AP (1) AP2001002165A0 (en)
AU (1) AU1555600A (en)
BR (1) BR9915639A (en)
CA (1) CA2352549A1 (en)
CZ (1) CZ20011821A3 (en)
DE (1) DE19854402A1 (en)
EA (1) EA200100586A1 (en)
IL (1) IL142776A0 (en)
NO (1) NO20012541L (en)
OA (1) OA11717A (en)
PL (1) PL348721A1 (en)
TR (1) TR200101433T2 (en)
WO (1) WO2000030625A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1603542A1 (en) * 2003-03-14 2005-12-14 Epistem Limited Treatment and/or prevention of non-viral epithelial damage
US20050171063A1 (en) * 2003-10-20 2005-08-04 Pawan Malhotra Use of phosphono derivatives as anti-malarials
US9808011B2 (en) 2014-12-15 2017-11-07 Biovectra Inc. Pentacyclic triterpene compounds and uses thereof
CN105794493A (en) * 2016-03-11 2016-07-27 钦州市凤源泉生物科技有限公司 Culture method for improving main active components of russule
KR101797926B1 (en) * 2016-11-21 2017-11-15 한국식품연구원 Composition for preventing or treating obesity or obesity-realated metabolic syndrome comprising formic acid or pharmaceutically acceptable salt thereof as an active ingredient
KR101912774B1 (en) * 2016-11-21 2018-10-29 한국식품연구원 Composition comprising a strain having formic acid producing ability for the preventing or treatment of obesity, or obesity-realated metabolic syndrome
CN108948005A (en) * 2018-07-03 2018-12-07 湖南华腾制药有限公司 Polyethyleneglycol modified Enoxacin and application
KR102641583B1 (en) * 2018-10-23 2024-02-28 건국대학교 산학협력단 Composition for preventing plant diseases comprising zidovudine
CN114983999A (en) * 2022-06-09 2022-09-02 四川大学 New application and verification method of artemisinin and derivatives thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603726D0 (en) * 1996-10-11 1996-10-11 Astra Ab Novel compounds

Also Published As

Publication number Publication date
WO2000030625A2 (en) 2000-06-02
IL142776A0 (en) 2002-03-10
TR200101433T2 (en) 2001-10-22
OA11717A (en) 2005-01-26
CN1328465A (en) 2001-12-26
NO20012541D0 (en) 2001-05-23
CA2352549A1 (en) 2000-06-02
WO2000030625A3 (en) 2000-10-05
AP2001002165A0 (en) 2001-06-30
EA200100586A1 (en) 2001-12-24
CZ20011821A3 (en) 2001-09-12
PL348721A1 (en) 2002-06-03
EP1131075A2 (en) 2001-09-12
AU1555600A (en) 2000-06-13
BR9915639A (en) 2001-08-07
JP2002530326A (en) 2002-09-17
DE19854402A1 (en) 2000-05-31

Similar Documents

Publication Publication Date Title
WO1999052515A3 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections
DK0507317T3 (en) Biguanide derivatives, processes for their preparation and disinfectants containing these derivatives
DK1483246T3 (en) 5-Substituted alkylaminopyrazole derivatives as pesticides
PL407615A1 (en) Novel 2-pyridinyl-ethyl-benzamide compound, the process for its preparation, the composition and method for fungicide combating fungi
YU2201A (en) Phosphorous organic compounds and their use
WO2000044359A3 (en) Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections
NO20012541L (en) Use of phosphonomauric acid derivatives for the treatment of infections
NO20011430L (en) Use of organophosphorus compounds for the manufacture of medicaments for the therapeutic and prophylactic treatment of infections, or as a fungicide, bactericide or herbicide propagate
NO20013167D0 (en) Use of bisphosphonates for the prevention and treatment of infection processes
ATE327980T1 (en) 3-HETEROCYCLYL SUBSTITUTED BENZOIC ACID DERIVATIVES
NO20012540L (en) Use of phosphonomauric acid derivatives for the treatment of infections
WO2000044358A3 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
ATE333796T1 (en) LIQUID ANTIMICROBIAL COMPOSITIONS
WO2003017766A3 (en) Herbicides made from substituted aryl ketones
NO20013464L (en) Use of 3-isoxazolidinones and hydroxylamino acids for the treatment of infections
NO20052774L (en) Topical preparations and their use for the treatment of aquatic animals subjected to disinfection and vaccination.
WO2001049668A3 (en) 4-aryl-1-difluoromethoxyimidazoles and use thereof as herbicides
RU2001119804A (en) Means for inhibiting the growth of sulfate reducing bacteria

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application